Clinical trials
Phase 2 trials in Guatemala
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
50 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 1 |
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 4 |
| 2008 | 5 |
| 2009 | 5 |
| 2011 | 2 |
| 2012 | 4 |
| 2013 | 2 |
| 2014 | 4 |
| 2016 | 2 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 3 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 36 |
| Active, not recruiting | 6 |
| Terminated | 5 |
| Unknown status | 2 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 9 |
| Merck Sharp & Dohme LLC | 7 |
| Hoffmann-La Roche | 6 |
| Lakefront Biotherapeutics NV | 3 |
| Boehringer Ingelheim | 2 |
| Daiichi Sankyo | 2 |
| Genentech, Inc. | 2 |
| Takeda | 2 |
| ActivX Biosciences, Inc. | 1 |
| Aperta Biosciences, LLC | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 9 |
| Arthritis, Rheumatoid | 5 |
| Asthma | 5 |
| Pulmonary Disease, Chronic Obstructive | 3 |
| Arthritis, Gouty | 2 |
| Breast Neoplasms | 2 |
| Lupus Erythematosus, Systemic | 2 |
| Lupus Nephritis | 2 |
| AIDS-Related Opportunistic Infections | 1 |
| Bacteremia | 1 |
Trials
Showing 76 to 50 of 50. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.